Lion Point Capital, LP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Lion Point Capital, LP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$22,045,000
-21.1%
1,160,307
+38.3%
5.91%
+12.9%
Q3 2021$27,926,000
+18.2%
839,128
+37.8%
5.24%
+28.2%
Q2 2021$23,628,000
-19.5%
609,1280.0%4.08%
-23.6%
Q1 2021$29,359,000
-57.5%
609,128
-54.1%
5.34%
-59.8%
Q4 2020$69,068,000
+94.4%
1,327,7340.0%13.30%
+70.7%
Q3 2020$35,530,000
+103.2%
1,327,734
+47.9%
7.79%
+83.7%
Q2 2020$17,489,000897,7994.24%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders